NSAID-INDUCED COLOPATHY: INCIDENCE, CLINICAL AND ENDOSCOPIC MANIFESTATIONS, POSSIBILITIES OF DRUG THERAPY ; НПВП-колопатии: частота, клинические и эндоскопические проявления, возможности медикаментозной терапии

Authors: A. P. Balabantseva, A. E. Karateev, А. П. Балабанцева, А. Е. Каратеев

Source: Rheumatology Science and Practice; Vol 56, No 5 (2018); 564-568 ; Научно-практическая ревматология; Vol 56, No 5 (2018); 564-568 ; 1995-4492 ; 1995-4484 ; undefined

Subject Terms: сульфасалазин, complications, colon, NSAID-induced colopathy, treatment, sulfasalazine, осложнения, толстая кишка, НПВП-колопатия, лечение

File Description: application/pdf

Relation: https://rsp.mediar-press.net/rsp/article/view/2618/1752; Каратеев АЕ, Насонов ЕЛ, Яхно НН и др. Клинические рекомендации «Рациональное применение нестероидных противовоспалительных препаратов (НПВП) в клинической практике». Современная ревматология. 2015;9(1):4-23 [Karateev AE, Nasonov EL, Yakhno NN, et al. Clinical guidelines «Rational use of nonsteroidal anti-inflammatory drugs (NSAIDs) in clinical practice ». Sovremennaya Revmatologiya = Modern Rheumatology Journal. 2015;9(1):4-23 (In Russ.)]. doi:10.14412/1996-7012-2015-1-4-23; Harirforoosh S, Asghar W, Jamali F. Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications. J Pharm Pharm Sci. 2013;16(5):821-47. doi:10.18433/J3VW2F; Lanas A, Boers M, Nuevo J. Gastrointestinal events in at-risk patients starting non-steroidal anti-inflammatory drugs (NSAIDs) for rheumatic diseases: the EVIDENCE study of European routine practice. Ann Rheum Dis. 2015 Apr;74(4):675-81. doi:10.1136/annrheumdis-2013-204155. Epub 2013 Dec 18.; Sostres C, Gargallo CJ, Lanas A. Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage. Arthritis Res Ther. 2013;15 Suppl 3:S3. doi:10.1186/ar4175. Epub 2013 Jul 24.; Debenham GP. Ulcer of the cecum during oxyphenbutazone (tandearil) therapy. Can Med Assoc J. 1966;94:1182-4.; Aftab AR, Donnellan F, Zeb F, et al. NSAID-induced colopathy. A case series. J Gastrointestin Liver Dis. 2010;19:89-91.; Aloysius MM, Kaye PV, Lobo DN. Non-steroidal anti-inflamatory drug (NSAID)-induced colonic strictures and perforation: a case report. Dig Liver Dis. 2006;38:276-8. doi:10.1016/j.dld.2005.09.003; Byrne MF, McGuinness J, Smyth CM, et al. Nonsteroidal antiinflammatory drug-induced diaphragms and ulceration in the colon. Eur J Gastroenterol Hepatol. 2002;14:1265-9. doi:10.1097/00042737-200211000-00017; El Hajj I, Hawchar M, Sharara A. NSAID-induced colopathy: case report andreview of the literature. J Med Liban. 2009;57:274-6.; Klein M, Linnemann D, Rosenberg J. Non-steroidal anti-inflammatory drug-induced colopathy. BMJ Case Rep. 2011 Feb 8;2011. pii: bcr1020103436. doi:10.1136/bcr.10.2010.3436; Bjarnason I, Macpherson AJ. Intestinal toxicity of non-steroidal anti-inflammatory drugs. Pharmacol Ther. 1994 Apr-May;62(1-2):145-57. doi:10.1016/0163-7258(94)90008-6; Schwake L, Schlenker T, Schwake S, et al. Ulcers of the colon in association with nonsteroidal anti-inflammatory drugs (NSAID) – a rare cause of gastrointestinal bleeding? Report of 3 cases. Z Gastroenterol. 2000 Dec;38(12):957-61. doi:10.1055/s-2000-10024; Lanas A, Sopena F. Nonsteroidal anti-inflammatory drugs and lower gastrointestinal complications. Gastroenterol Clin North Am. 2009 Jun;38(2):333-52. doi:10.1016/j.gtc.2009.03.007; Каратеев АЕ, Галушко ЕА. Поражение кишечника у больных спондилоартритами. Научно-практическая ревматология. 2015;53(2):190-9 [Karateev AE, Galushko EA. Bowel involvement in patients with spondyloarthritis. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2015;53(2):190-9 (In Russ.)]. doi:10.14412/1995-4484-2015-190-199; Munipalle PC, Garud T, Light D. Diaphragmatic disease of the colon: systematic review. Colorectal Dis. 2013 Sep;15(9):1063-9. doi:10.1111/codi.12218; Kü ttner Magalhaes R, Ferreira JM, Pedroto I. Nonsteroidal antiinflammatory drug (NSAID)-induced colopathy with diaphragmlike strictures. J Gastrointestin Liver Dis. 2014 Mar;23(1):9.; Laine L, Curtis SP, Langman M, et al. Lower gastrointestinal events in a double-blind trial of the cyclo-oxygenase-2 selective inhibitor etoricoxib and the traditional nonsteroidal anti-inflammatory drug diclofenac. Gastroenterology. 2008;135:1517-25. doi:10.1053/j.gastro.2008.07.067; Nagata N, Niikura R, Aoki T, et al. Lower GI bleeding risk of nonsteroidal anti-inflammatory drugs and antiplatelet drug use alone and the effect of combined therapy. Gastrointest Endosc. 2014 Dec;80(6):1124-31. doi:10.1016/j.gie.2014.06.039. Epub 2014 Aug 1.; Masannat YA, Harron M, Harinath G. Nonsteroidal anti-inflammatory drugs-associated colopathy. ANZ J Surg. 2010 Jan;80(1-2):96-9. doi:10.1111/j.1445-2197.2009.05180.x; Davies NM. Toxicity of nonsteroidal anti-inflammatory drugs in the large intestine. Dis Colon Rectum. 1995 Dec;38(12):1311-21. doi:10.1007/BF02049158; Kurahara K, Matsumoto T, Iida M. Characteristics of nonsteroidal anti-inflammatory drugs-induced colopathy. Nihon Rinsho. 2011 Jun;69(6):1098-103.; Pardi DS. Diagnosis and Management of Microscopic Colitis. Am J Gastroenterol. 2017 Jan;112(1):78-85. doi:10.1038/ajg.2016.477. Epub 2016 Nov 29.; Park T, Cave D, Marshall C. Microscopic colitis: A review of etiology, treatment and refractory disease. World J Gastroenterol. 2015 Aug 7;21(29):8804-10. doi:10.3748/wjg.v21.i29.8804; Tsuruoka N, Iwakiri R, Hara M, et al. NSAIDs are a significant risk factor for colonic diverticular hemorrhage in elder patients: evaluation by a case-control study. J Gastroenterol Hepatol. 2011 Jun;26(6):1047-52. doi:10.1111/j.1440-1746.2010.06610.x; Kirsch M. Nonsteroidal antiinflammatory drug colopathy: mimicry of Crohn's disease and colon carcinoma. J Clin Gastroenterol. 1997 Mar;24(2):121-3. doi:10.1097/00004836-199703000-00019; Stolte M, Hartmann FO. Misinterpretation of NSAID-induced Colopathy as Crohn's disease. Z Gastroenterol. 2010 Apr;48(4):472-5. doi:10.1055/s-0028-1109760. Epub 2010 Feb 5.; Coward S, Kuenzig ME, Hazlewood G, et al. Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohn's Disease: A Bayesian Network Meta-analysis. Inflamm Bowel Dis. 2017 Mar;23(3):461-72. doi:10.1097/MIB.0000000000001023; Lim WC, Wang Y, MacDonald JK, Hanauer S. Aminosalicylates for induction of remission or response in Crohn's disease. Cochrane Database Syst Rev. 2016 Jul 3;7:CD008870. doi:10.1002/14651858.CD008870.pub2.; Cohen HD, Das KM. The metabolism of mesalamine and its possible use in colonic diverticulitis as an anti-inflammatory agent. J Clin Gastroenterol. 2006 Aug;40 Suppl 3:S150-4. doi:10.1097/01.mcg.0000212654.28527.d0; Sinagra E, Morreale GC, Mohammadian G, et al. New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond. World J Gastroenterol. 2017 Sep 28;23(36):6593-627. doi:10.3748/wjg.v23.i36.6593

Availability: https://rsp.mediar-press.net/rsp/article/view/2618
https://doi.org/10.14412/1995-4484-2018-564-568

The frequency and clinical and endoscopic features of mixed NSAIDs-induced gastrointestinal injuries ; Частота и клинико-эндоскопические особенности сочетанных НПВП-индуцированных гастроинтестинальных повреждений

Authors: A. P. Balabantseva, A. E. Karateev, А. П. Балабанцева, А. E. Каратеев

Source: Modern Rheumatology Journal; Том 12, № 4 (2018); 95-100 ; Современная ревматология; Том 12, № 4 (2018); 95-100 ; 2310-158X ; 1996-7012 ; 10.14412/1996-7012-2018-4

Subject Terms: факторы риска, NSAID-induced gastropathy, NSAID-induced enteropathy, NSAID-induced colopathy, mixed injury, risk factors, НПВП-гастропатия, НПВП-энтеропатия, НПВП-колопатия, сочетанное поражение

File Description: application/pdf

Relation: https://mrj.ima-press.net/mrj/article/view/868/835; Каратеев АЕ, Насонов ЕЛ, Ивашкин ВТ и др. Рациональное использование нестероидных противовоспалительных препаратов. Клинические рекомендации. Научно-практическая ревматология. 2018;56(S1): 1-29. doi:10.14412/rjtao20180; Harirforoosh S, Asghar W, Jamali F. Adverse Effects of Nonsteroidal Antiinflammatory Drugs: An Update of Gastrointestinal, Cardiovascular and Renal Complications. J Pharm Pharm Sci. 2013; 16(5):821-47.; Melcarne L, Garcia-Iglesias P, Calvet X. Management of NSAID-associated peptic ulcer disease. Expert Rev Gastroenterol Hepatol. 2016 Jun;10(6):723-33. doi:10.1586/17474124.2016.1142872. Epub 2016 Mar 2.; Goldstein JL, Cryer B. Gastrointestinal injury associated with NSAID use: a case study and review of risk factors and preventative strategies. Drug Healthc Patient Saf. 2015 Jan 22;7:31-41. doi:10.2147/DHPS.S71976. eCollection 2015.; Вахрушев ЯМ, Загребина ЕА. Энтеропатия, индуцированная нестероидными противовоспалительными препаратами (патогенез, диагностика, лечение). Терапевтический архив. 2012;(5):74-9.; Huang L, Huang Z, Tai Y, et al. The small bowel diseases detected by capsule endoscopy in patients with chronic abdominal pain: A retrospective study. Medicine (Baltimore). 2018 Feb;97(8):e0025. doi:10.1097/MD.0000000000010025.; Tai FWD, McAlindon ME. NSAIDs and the small bowel. Curr Opin Gastroenterol. 2018 May;34(3):175-182. doi:10.1097/MOG.0000000000000427.; Laine L, Curtis SP, Langman M, et al. Lower gastrointestinal events in a doubleblind trial of the cyclo-oxygenase-2 selective inhibitor etoricoxib and the traditional nonsteroidal anti- inflammatory drug diclofenac. Gastroenterology. 2008 Nov;135(5):1517-25. doi:10.1053/j.gastro.2008.07.067. Epub 2008 Aug 3.; Klein M, Linnemann D, Rosenberg J. Non-steroidal anti-inflammatory druginduced colopathy. BMJ Case Rep. 2011 Feb 8;2011. pii: bcr1020103436. doi:10.1136/bcr.10.2010.3436.; Sostres C, Gargallo CJ, Lanas A. Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage. Arthritis Res Ther. 2013;15 Suppl 3:S3. doi:10.1186/ar4175. Epub 2013 Jul 24.; Lanas A, Sopena F. Nonsteroidal antiinflammatory drugs and lower gastrointestinal complications. Gastroenterol Clin North Am. 2009 Jun;38(2):333-52. doi:10.1016/j.gtc.2009.03.007.; Lanas A, Boers M, Nuevo J. Gastrointestinal events in at-risk patients starting non-steroidal anti-inflammatory drugs (NSAIDs) for rheumatic diseases: the EVIDENCE study of European routine practice. Ann Rheum Dis. 2015 Apr;74(4): 675-81. doi:10.1136/annrheumdis-2013-204155. Epub 2013 Dec 18.; Maiden L, Thjodleifsson B, Seigal A, et al. Long-term effects of nonsteroidal antiinflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a crosssectional capsule enteroscopy study. Clin Gastroenterol Hepatol. 2007 Sep;5(9):1040-5. Epub 2007 Jul 10.; Caunedo-Alvarez A, Gomez-Rodriguez BJ, Romero-Vazquez J, et al. Macroscopic small bowel mucosal injury caused by chronic nonsteroidal anti-inflammatory drugs (NSAID) use as assessed by capsule endoscopy. Rev Esp Enferm Dig. 2010 Feb;102(2):80-5. 15. Tacheci I, Bradna P, Douda T, et al. Small intestinal injury in NSAID users suffering from rheumatoid arthritis or osteoarthritis. Rheumatol Int. 2016 Nov;36(11): 1557-1561. Epub 2016 Aug 22.; Syer SD, Blackler RW, Martin R, et al. NSAID enteropathy and bacteria: a complicated relationship. J Gastroenterol. 2015 Apr; 50(4):387-93. doi:10.1007/s00535-014-1032-1. Epub 2015 Jan 10.; Xiao X, Nakatsu G, Jin Y, et al. Gut Microbiota Mediates Protection Against Enteropathy Induced by Indomethacin. Sci Rep. 2017 Jan 9;7:40317. doi:10.1038/srep40317.; Gilis E, Mortier C, Venken K, et al. The Role of the Microbiome in Gut and Joint Inflammation in Psoriatic Arthritis and Spondyloarthritis. J Rheumatol Suppl. 2018 Jun; 94:36-39. doi:10.3899/jrheum.180135.; Каратеев АЕ, Галушко ЕА. Поражение кишечника у больных спондилоартритами. Научно-практическая ревматология. 2015;53(2):190-9. doi:10.14412/1995-4484-2015-190-199; Musumba CO, Jorgensen A, Sutton L, et al. CYP2C19*17 gain-of-function polymorphism is associated with peptic ulcer disease. Clin Pharmacol Ther. 2013 Feb;93(2): 195-203. doi:10.1038/clpt.2012.215. Epub 2012 Oct 26.; Klotz U. Clinical impact of CYP2C19 polymorphism on the action of proton pump inhibitors: a review of a special problem. Int J Clin Pharmacol Ther. 2006 Jul;44(7):297-302.; Nuki Y, Umeno J, Washio E, et al. The influence of CYP2C19 polymorphisms on exacerbating effect of rabeprazole in celecoxib-induced small bowel injury. Aliment Pharmacol Ther. 2017 Aug;46(3):331-336. doi:10.1111/apt.14134. Epub 2017 May 8.; Lue A, Lanas A. Protons pump inhibitor treatment and lower gastrointestinal bleeding: Balancing risks and benefits. World J Gastroenterol. 2016 Dec 28;22(48): 10477-10481. doi:10.3748/wjg.v22.i48.10477.; Wallace JL, Syer S, Denou E, et al. Proton pump inhibitors exacerbate NSAIDinduced small intestinal injury by inducing dysbiosis. Gastroenterology. 2011 Oct; 141(4):1314-22, 1322.e1-5. doi:10.1053/j.gastro.2011.06.075. Epub 2011 Jul 13.; Verhaegh B, de Vries F, Masclee AA, et al. High risk of drug-induced microscopic colitis with concomitant use of NSAIDs and proton pump inhibitors. Aliment Pharmacol Ther. 2016 May;43(9):1004-13. doi:10.1111/apt.13583. Epub 2016 Mar 9.; Мороз ЕВ, Каратеев АЕ. Ребамипид: эффективная медикаментозная профилактика НПВП-энтеропатии возможна. Современная ревматология. 2016;10(4): 97-105. doi:10.14412/1996-7012-2016-4-97-105

Availability: https://mrj.ima-press.net/mrj/article/view/868
https://doi.org/10.14412/1996-7012-2018-4-95-100